ARPA-H POSEIDON project awarded to CMU/Ginkgo Bioworks team!
Honored and thrilled to represent the team as PI for this ARPA-H POSEIDON project, which brings together phenomenal researchers across academia and industry. We come from CMU engineering, Ginkgo Bioworks, the University of Pittsburgh, Platypus Bio NZ, the University of Massachusetts Amherst, KU Leuven, and Velentium Medical.
In this ambitious project we aim to tackle one of the grand challenges in cancer medicine, the early detection of stage 1 tumors, with the aim of making cancer detection affordable and convenient for everyone! Read the CMU press release here.